Egetis Therapeutics
Sweden - Stockholm
PharmaceuticalFocus: Specialty Pharmaceuticals
Egetis Therapeutics is a life sciences company focused on Specialty Pharmaceuticals.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Tiratricol
Monocarboxylate Transporter 8 DeficiencyClinical Trials (1)
NCT05911399Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency
N/APP100-01
Paracetamol OverdoseClinical Trials (1)
NCT03177395PP100-01 (Calmangafodipir) for Overdose of Paracetamol
Phase 1Calmangafodipir
Chemotherapy Induced Peripheral Neuropathy (CIPN)Clinical Trials (1)
NCT03430999SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects
Phase 1Phase 1/2
Clinical Trials (1)
NCT01619423A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
Phase 1/2Mangafodipir
Myocardial InfarctionClinical Trials (1)
NCT00966563Mangafodipir as an Adjunct to Percutaneous Coronary Intervention
Phase 2Mangafodipir
ChemotherapyClinical Trials (1)
NCT00671996Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C
Phase 2Calmangafodipir
Colorectal CancerClinical Trials (1)
NCT04034355Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer
Phase 3Tiratricol
Monocarboxylate Transporter 8 DeficiencyClinical Trials (1)
NCT05579327Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)
Phase 3Calmangafodipir
Colorectal CancerClinical Trials (1)
NCT03654729Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 9 clinical trials